SCHEMBL752095

SCHEMBL752095

N#CCC(=O)C1CC1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5466115 0.97
SCHEMBL2705709 0.91 PLG (0.43)
SCHEMBL239077 0.90
SCHEMBL573499 0.90 ALDH1A1 (0.47)
SCHEMBL25278102 0.89 ALDH1A1 (0.41)
SCHEMBL1543551 0.89 MCL1 (0.39)
SCHEMBL25278103 0.89 ALDH1A1 (0.41)
SCHEMBL20852085 0.88 ALDH1A1 (0.50)
SCHEMBL4842055 0.88 ALDH1A1 (0.50)
SCHEMBL26722615 0.88 ALDH1A1 (0.50)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 415 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20170088513-A1 2-CYANO-3-CYCLOPROPYL-3-HYDROXY-N-ARYL-THIOACRYLAMIDE DERIVATIVES ALGIAX PHARMACEUTICALS GMBH (DE) 2017-03-30 US claimed
EP-3119744-A1 2-CYANO-3-CYCLOPROPYL-3-HYDROXY-N-ARYL-THIOACRYLAMIDE DERIVATIVES Algiax Pharmaceuticals GmbH (DE) 2017-01-25 EP claimed
WO-2015140081-A1 2-CYANO-3-CYCLOPROPYL-3-HYDROXY-N-ARYL-THIOACRYLAMIDE DERIVATIVES ALGIAX PHARMACEUTICALS GMBH (DE) 2015-09-24 WO claimed
EP-1361215-B1 PROCESS FOR PRODUCING QUINOLINE CARBOXYALDEHYDE DERIVATIVE AND INTERMEDIATE THEREOF NISSAN CHEMICAL IND LTD (JP) 2012-03-21 EP claimed
US-6841681-B2 Process for producing quinoline carboxyaldehyde derivative and intermediate thereof NISSAN CHEMICAL INDUSTRIES, LTD. (JP) 2005-01-11 US claimed
US-20040077866-A1 Process for producing quinoline carboxyaldehyde derivative and intermediate thereof NISSAN CHEMICAL INDUSTRIES, LTD. (JP) 2004-04-22 US claimed
EP-1361215-A1 PROCESS FOR PRODUCING QUINOLINE CARBOXYALDEHYDE DERIVATIVE AND INTERMEDIATE THEREOF Nissan Chemical Industries, Ltd. (JP) 2003-11-12 EP claimed
EP-4741018-A2 SULPHONAMIDE COMPOUNDS Anaxis Pharma Pty Ltd (AU) 2026-05-13 EP disclosed
CN-122029151-A Statin derivatives and methods of use thereof 通用医疗公司 2026-05-12 CN disclosed
US-12611404-B2 Aza-aryl 1H-pyrazol-1-yl benzene sulfonamides CHEMOCENTRYX, INC. (US) 2026-04-28 US disclosed
EP-4724426-A1 STATIN DERIVATIVES AND METHODS OF USING THE SAME The General Hospital Corporation (US) 2026-04-15 EP disclosed
US-12583836-B2 Sulphonamide compounds Anaxis Pharma Pty Ltd (AU) 2026-03-24 US disclosed
US-20260035341-A1 FTO INHIBITORS RPXDS CO LTD (CN) 2026-02-05 US disclosed
EP-0326107-B1 ANTIARTHRITIC BETA-CYCLOALKYL-BETA-OXOPROPIONITRILES Bristol-Myers Squibb Company (US) 1992-09-02 EP disclosed
CN-1063682-A Novel herbicide RHONE POULENC AGRICULTURE (GB) 1992-08-19 CN disclosed
EP-0496631-A1 2-Cyano-1,3-dione herbicides RHONE-POULENC AGRICULTURE LTD. (GB) 1992-07-29 EP disclosed
EP-0496630-A1 2-Cyano-1,3-dione herbicides RHONE-POULENC AGRICULTURE LTD. (GB) 1992-07-29 EP disclosed
EP-0490587-A1 Substituted pyrazolopyrimidines and imidazopyridazines as angiotensin II antagonists MERCK & CO. INC. (US) 1992-06-17 EP disclosed
US-4888357-A ANTIINFLAMMATORY AGENTS BRISTOL-MYERS COMPANY (US) 1989-12-19 US disclosed
EP-0326107-A1 Antiarthritic beta-cycloalkyl-beta-oxopropionitriles Bristol-Myers Squibb Company (US) 1989-08-02 EP disclosed